Loading…
PolyPid Ltd. is projected to rise to $6.66 by 2027, a +40% move from its current price of $4.77. PYPD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.65 | $4.77 | $4.89 | +0.03% |
| May 30 | $4.61 | $4.77 | $4.95 | +0.06% |
| May 31 | $4.57 | $4.77 | $4.99 | +0.09% |
| Jun 1 | $4.54 | $4.78 | $5.02 | +0.12% |
| Jun 2 | $4.52 | $4.78 | $5.05 | +0.15% |
| Jun 3 | $4.49 | $4.78 | $5.08 | +0.18% |
| Jun 4 | $4.47 | $4.78 | $5.11 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.47 | $4.78 | $5.11 | +0.21% |
| Week 2 | $4.36 | $4.79 | $5.26 | +0.42% |
| Week 3 | $4.28 | $4.80 | $5.38 | +0.63% |
| Week 4 | $4.21 | $4.81 | $5.49 | +0.84% |
| Week 5 | $4.16 | $4.82 | $5.59 | +1.05% |
| Week 6 | $4.11 | $4.83 | $5.68 | +1.27% |
| Week 7 | $4.06 | $4.84 | $5.77 | +1.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PolyPid Ltd. is a biopharmaceutical company developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions.
The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. It has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors.
PolyPid Ltd. (PYPD) is a Healthcare sector asset with a current price of $5.02 and a market capitalization of $96.25M. It is ranked 4252 by market capitalization and visibility among peers.
The price outlook in the provided forecast shows upside potential beyond 2026, with a path of rising average prices over time. The 2026 avg price is $5.02, and the forecast envisions a rise to $9.12 by 2030, $25.71 by 2040, and $44.81 by 2050, alongside max values of $13.11 (2030), $42.51 (2040), and $80.70 (2050). The implied returns grow over time, with ROI figures highlighted for later years (81.7% by 2030, 412.1% by 2040, and 792.7% by 2050), and sentiment remains bullish in those years.
A major floor 18.9% below — a decisive break under it would weaken the trend.
The nearest floor, 11.5% below — buyers have tended to step in here.
The nearest ceiling, 5.2% above — a clean break opens room to run.
A major ceiling 14.7% above — clearing it would confirm fresh momentum.
Key PYPD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PYPD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.86 | Sell | $4.81 | Sell |
| MA 10 | $4.69 | Buy | $4.74 | Buy |
| MA 20 | $4.58 | Buy | $4.64 | Buy |
| MA 50 | $4.48 | Buy | $4.52 | Buy |
| MA 100 | $4.47 | Buy | $4.38 | Buy |
| MA 200 | $4.04 | Buy | $4.15 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.92 | Neutral |
| Stoch RSI (14) | 58.96 | Neutral |
| CCI (20) | 73.22 | Neutral |
| Williams %R (14) | -31.25 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 8.90 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 68.75 | Neutral |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | 0.29 | Buy |
| Ultimate (7,14,28) | 63.02 | Neutral |
| Momentum (10) | 0.21 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 4.95 | Sell |
| ADX (14) | 13.30 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture points to a bullish posture. RSI(14) sits at 70, signaling strong near-term momentum.
Shares trade above the 50-day simple moving average of $4.46 and above the 200-day simple moving average of $4.02, suggesting a positive trend relative to longer-term averages.
Key intraday markers show support at $4.22 and resistance at $5.02, with the 30-day price range spanning $4.25 to $5.93, indicating a relatively tight trading window in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.08 | $4.77 | $6.63 | 0% | Neutral | |
| $5.33 | $6.66 | $8.80 | +40% | Bullish | |
| $5.59 | $7.17 | $9.80 | +50% | Bullish | |
| $5.57 | $7.29 | $10.23 | +53% | Bullish | |
| $6.23 | $8.31 | $11.92 | +74% | Bullish | |
| $6.49 | $8.79 | $12.86 | +84% | Bullish | |
| $7.61 | $10.47 | $15.59 | +120% | Bullish | |
| $9.21 | $12.86 | $19.45 | +170% | Bullish | |
| $9.23 | $13.08 | $20.07 | +174% | Bullish | |
| $10.02 | $14.39 | $22.39 | +202% | Bullish | |
| $14.62 | $22.28 | $36.72 | +367% | Bullish | |
| $22.32 | $37.68 | $67.60 | +690% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.08 | $4.77 | $5.63 | +0.00% |
| June 2026 | $4.23 | $4.96 | $5.95 | +4.01% |
| July 2026 | $4.15 | $4.90 | $5.95 | -1.20% |
| August 2026 | $4.11 | $4.88 | $5.98 | -0.38% |
| September 2026 | $4.22 | $5.04 | $6.23 | +3.30% |
| October 2026 | $4.26 | $5.11 | $6.35 | +1.27% |
| November 2026 | $4.21 | $5.07 | $6.35 | -0.65% |
| December 2026 | $4.36 | $5.27 | $6.63 | +3.80% |
Click any year to see its month-by-month PYPD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PYPD to range from $4.08 to $6.63 through 2026. The $4.77 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The PYPD price prediction for 2027 points to an average of $6.66 (low $5.33, high $8.80) — a potential gain of +40% on today's $4.77. Buyers look set to stay in control over this stretch.
In 2028, PYPD is projected to trade between $5.59 and $9.80, averaging $7.17 — a potential gain of +50% from today's $4.77. That is up +8% on the projected 2027 average. Momentum favours further upside here.
PolyPid Ltd.'s 2029 outlook centres on $7.29, within a $5.57 to $10.23 range. That is up +2% on the projected 2028 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, PYPD could reach as high as $11.92, with a base case around $8.31 and support toward $6.23 — roughly +74% from $4.77. Momentum favours further upside here.
Expect PYPD to range from $6.49 to $12.86 through 2031. The $8.79 average target implies a +84% move from current prices. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The PYPD price prediction for 2032 points to an average of $10.47 (low $7.61, high $15.59) — a potential gain of +120% on today's $4.77. Momentum favours further upside here.
In 2033, PYPD is projected to trade between $9.21 and $19.45, averaging $12.86 — a potential gain of +170% from today's $4.77. That is up +23% on the projected 2032 average. Buyers look set to stay in control over this stretch.
PolyPid Ltd.'s 2034 outlook centres on $13.08, within a $9.23 to $20.07 range. That is up +2% on the projected 2033 average. That marks a +174% change versus current levels. Momentum favours further upside here.
By 2035, PYPD could reach as high as $22.39, with a base case around $14.39 and support toward $10.02 — roughly +202% from $4.77. Buyers look set to stay in control over this stretch.
Expect PYPD to range from $14.62 to $36.72 through 2040. The $22.28 average target implies a +367% move from current prices. That is up +55% on the projected 2035 average. Momentum favours further upside here.
The PYPD price prediction for 2050 points to an average of $37.68 (low $22.32, high $67.60) — a potential gain of +690% on today's $4.77. Buyers look set to stay in control over this stretch.
Investing $1,000 in PYPD today (≈ 209.643606 PYPD) could be worth
$7,898.42
+$6,898.42 (+690%) by 2050 · US Dollar
Based on the average projected PYPD price of $37.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PYPDwould be worth at today's price.
$1,000 invested in PYPD on May 27, 2025 (≈ 392.15687 PYPD) would be worth
$1,870.59
+$870.59 (+87.1%) today · 1.87× · US Dollar
Based on a PYPD entry price of $2.55 vs. today's $4.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.85 | $983.51 | -1.6% |
| 1 month ago | $4.58 | $1,041.48 | +4.1% |
| 3 months ago | $4.22 | $1,130.33 | +13.0% |
| 6 months ago | $3.95 | $1,207.59 | +20.8% |
| 1 year ago | $2.55 | $1,870.59 | +87.1% |
| All time (5.0y) ago | $281.1 | $16.97 | -98.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PYPD forecast.
Our base-case forecast reaches $9.50 around 2032.
Implied market cap at $9.50: $182.15M
The multi-year forecast outlines a bullish trajectory for PolyPid, with the avg price trending higher in successive years. The 2026 avg is $5.02 and the 2035 avg is $16.40, with ROI rising from 0% in 2026 to 226.7% by 2035, underscoring growing projected upside.
By 2030, the avg price is $9.12 with ROI 81.7%. The forecast continues to imply substantial upside through 2040 and 2050, with the 2040 avg at $25.71 and ROI 412.1%, and the 2050 avg at $44.81 and ROI 792.7%.
Overall, the sentiment remains BULLISH across the longer horizon, supported by the forward-looking figures in the forecast. These are estimates, not guarantees, and actual results may differ due to clinical progress, regulatory outcomes, and market dynamics.
Tap a question to reveal the answer.
2030 min $6.83, avg $9.12, max $13.11; ROI 81.7%; sentiment BULLISH.
Forecasts show a bullish path from 2027 onward with avg prices rising (e.g., 2027 avg $7.12; ROI 41.8%; 2030 avg $9.12; ROI 81.7%; 2040 avg $25.71; ROI 412.1%; 2050 avg $44.81; ROI 792.7%), though 2026 is listed as neutral. These are estimates, not guarantees.
Yes, the forecast lists a 2050 max of $80.70 and a 2050 avg of $44.81.
Current price is $5.02 and market cap is $96.25M.
Sentiment is BULLISH; RSI(14) is 70. SMA50 is $4.46 and SMA200 is $4.02. Support is at $4.22 and resistance at $5.02. The 30-day range is $4.25 to $5.93.
PolyPid Ltd. Community Discussion
0Share your PolyPid Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.